ZJB

(2R,3R,4S,5R)-2-(3-AMINO-5-METHYL-1,4,5,6,8-PENTAAZAACENAPHTHYLEN-1(5H)-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL

Created:	2015-09-22
Last modified:	2016-10-05

Find Related PDB Entry
1 entries where ZJB is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	39
Chiral Atom Count	4
Bond Count	42
Aromatic Bond Count	10

2D diagram of ZJB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R,3R,4S,5R)-2-(3-AMINO-5-METHYL-1,4,5,6,8-PENTAAZAACENAPHTHYLEN-1(5H)-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL
Formula	C₁₃ H₁₆ N₆ O₄
Molecular Weight	320.304
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CN1N=C(N)c2cn([CH]3O[CH](CO)[CH](O)[CH]3O)c4ncnc1c24
SMILES	OpenEye OEToolkits	1.7.6	CN1c2c3c(cn(c3ncn2)C4C(C(C(O4)CO)O)O)C(=N1)N
Canonical SMILES	CACTVS	3.385	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c4ncnc1c24
Canonical SMILES	OpenEye OEToolkits	1.7.6	CN1c2c3c(cn(c3ncn2)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=N1)N
InChI	InChI	1.03	InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8-,9-,13-/m1/s1
InChIKey	InChI	1.03	HOGVTUZUJGHKPL-HTVVRFAVSA-N

Drug Info: DrugBank

DrugBank ID	DB12405
Name	Triciribine
Groups	investigational
Description	Triciribine has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative, Breast Adenocarcinoma, and Stage IV Breast Cancer, among others.
Synonyms	Triciribine phosphate Triciribine Triciribinum TCN Triciribina Pentaazacentopthylene
Categories	Nucleic Acids, Nucleotides, and Nucleosides Nucleosides
CAS number	35943-35-2

Related Resource References

Resource Name	Reference
PubChem	65399
ChEMBL	CHEMBL331237
ChEBI	CHEBI:65310

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.